Treace Medical Concepts (TMCI) Total Debt (2020 - 2026)

Treace Medical Concepts' Total Debt history runs 7 years deep, the most recent figure standing at $57.6 million for Q1 2026.

• Quarterly Total Debt rose 7.81% year-over-year to $57.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $57.6 million (up 7.81% YoY) and the FY2025 annual result came in at $57.3 million, up 7.55% from the prior year.
• Total Debt was $57.6 million for Q1 2026 at Treace Medical Concepts, roughly flat from $57.3 million in the prior quarter.
• Across five years, Total Debt topped out at $57.6 million in Q1 2026 and bottomed at $29.4 million in Q1 2022.
• A 5-year average of $52.3 million and a median of $53.1 million in 2024 frame the typical range for Total Debt.
• Annual changes were most pronounced in 2022 — Total Debt surged 79.53% — and 2024, when it climbed 0.56%.
• Treace Medical Concepts' Total Debt stood at $52.7 million in 2022, then advanced by 0.56% to $53.0 million in 2023, then advanced by 0.56% to $53.3 million in 2024, then climbed by 7.55% to $57.3 million in 2025, then gained by 0.47% to $57.6 million in 2026.
• Business Quant data shows TMCI's Total Debt at $57.6 million in Q1 2026, $57.3 million in Q4 2025, and $55.3 million in Q3 2025.